|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
My research offered a new way to look at schizophrenia-spectrum disorders. Abnormalities in the latent-cause inference process may be underlying schizotypy and schizophrenia-spectrum disorders.…
Date
April 27th, 2022 Speaker
Sofiya Yusina Department
Neuroscience
|
|
The opioid epidemic is a crisis that has plagued the United States (US) for decades. One of the central issues of the epidemic is inequitable access to treatment for opioid use disorder (OUD), which…
Date
April 27th, 2022 Speaker
Joyce Luo Department
Operations Research and Financial Engineering
|
|
|
|
Comparing Routes of Administration of CAR-T Cell Therapy in Glioblastoma Mouse Models
Date
July 29th, 2021 Speaker
Tristan Szapary Department
Department of Neurosurgery, UPENN
|
|
Psilocybin Assisted Therapy for Cocaine Use Disorder
Date
July 26th, 2021 Speaker
Camilla Strauss Department
Neuroscience Department, UAB
|
|
Tuberculosis remains a major health issue in the world today with over 10 million cases a year. Delamanid (Deltyba) is a new drug for the treatment of multidrug-resistant TB that was approved in…
Speaker
Satya K Nayagam, UG '22 Department
Chemical and Biological Engineering
|